AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 294: R1474-R1481, 2008. First published March 19, 2008; doi:10.1152/ajpregu.00130.2008
0363-6119/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/R1474    most recent
00130.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kambe, T.
Right arrow Articles by Andrews, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kambe, T.
Right arrow Articles by Andrews, G. K.

GENETICALLY MODIFIED ANIMALS AND MODEL ORGANISMS

Slc39a1 to 3 (subfamily II) Zip genes in mice have unique cell-specific functions during adaptation to zinc deficiency

Taiho Kambe,1,* Jim Geiser,1,* Brett Lahner,2 David E. Salt,2 and Glen K. Andrews1

1Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas; and 2Purdue University Ionomics Facility, Purdue University, West Lafayette, Indiana

Submitted 22 February 2008 ; accepted in final form 17 March 2008


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Subfamily II of the solute carrier (Slc)39a family contains three highly conserved members (ZIPs 1–3) that share a 12-amino acid signature sequence present in the putative fourth transmembrane domain and function as zinc transporters in transfected cells. The physiological significance of this genetic redundancy is unknown. Here we report that the complete elimination of all three of these Zip genes, by targeted mutagenesis and crossbreeding mice, causes no overt phenotypic effect. When mice were fed a zinc-adequate diet, several indicators of zinc status were indistinguishable between wild-type and triple-knockout mice, including embryonic morphogenesis and growth, alkaline phosphatase activity in the embryo, ZIP4 protein in the visceral yolk sac, and initial rates (30 min) of accumulation/retention of 67Zn in liver and pancreas. When mice were fed a zinc-deficient diet, embryonic membrane-bound alkaline phosphatase activity was reduced to a much greater extent, and 80% of the embryos of the triple-knockout mice developed abnormally compared with 12% of the embryos of wild-type mice. During zinc deficiency, the accumulation/retention (3 h) of 67Zn in the liver and pancreas of weanlings was significantly impaired in the triple-knockout mice compared with wild-type mice. Thus none of these three mammalian Zip genes apparently plays a critical role in zinc homeostasis when zinc is replete, but they play important, noncompensatory roles when this metal is deficient.

pregnancy; stable zinc isotope; triple-knockout mice; zinc homeostasis


THE MAINTENANCE OF ZINC HOMEOSTASIS is critical, and multiple genes have evolved to modulate the storage, efflux, and uptake of this essential metal in response to its availability. In mice it is estimated that 28 different genes may contribute to zinc homeostasis. Two superfamilies of mammalian zinc transporters have been identified that belong to the solute carrier (Slc)30a and Slc39a families (16, 32, 41). Slc30a members, named ZnTs, function in zinc efflux and compartmentalization and are cation diffusion facilitator proteins (32). Members of the Slc39a family, named ZIPs, function in the uptake of zinc and other metals (12, 16, 41). In mice and humans there are 14 members of the ZIP family, most of which can be grouped into one of two subfamilies named subfamily II (3 members) and LIV-1 (9 members). Many of these zinc transporters are expressed in a tissue-specific manner and in specific cellular localizations. In addition, they can display specific changes in cellular localization and stability in response to zinc deficiency or excess (4, 11, 22, 44).

Mutations in many of the members of the ZnT family and a few of the ZIP family members have begun to suggest their physiological functions. The mouse Znt1 gene is essential during early development and may be involved in the transfer of zinc into the conceptus (1), whereas the Znt3 gene is expressed in neurons and is important for the acquisition of zinc in synaptic vesicles (3). Mutations in the mouse Znt4 gene and the human Znt2 gene have been associated with a loss or reduction, respectively, of zinc in milk (2, 18). Znt5-knockout mice survive but have multiple abnormalities in muscle and bone (20), probably due to impaired transport of zinc into the secretory compartment (36). Znt7-knockout mice also fail to thrive, have low body fat, and show diminished acquisition and distribution of dietary zinc (17), perhaps also reflecting impaired zinc transport into the Golgi apparatus (25). Less is known about the genetics of mammalian Zip genes. Mutations in human Zip4 cause the rare and fatal recessive disease acrodermatitis enteropathica (27, 43), and the mouse Zip4 gene is essential for early embryonic development and may be involved in the transfer of zinc via the visceral yolk sac into the embryo and later in uptake of dietary zinc (10).

Our previous studies of three members of the ZIP subfamily II (8) revealed that targeted deletion of mouse Zip1, 2, or 3 did not cause overt signs of zinc deficiency but did lead to an impaired ability to adapt to zinc deficiency (5, 6, 33). Analyses of single- and double-knockout mice with no functional Zip1 and/or Zip3 suggested that they contribute essentially additively to the degree of sensitivity to zinc deficiency during pregnancy (6). Analysis of the patterns of expression of these genes in mice revealed coexpression in intestinal stromal cells, nephric tubular epithelial cells, pancreatic ductal epithelial cells, and hepatocytes surrounding the central vein, as well as some unique cell-specific expression patterns (5, 6). This suggested that these zinc transporters might exert some compensatory functions in the redistribution and/or retention of zinc rather than its acquisition from the diet (6, 8). In contrast, the expression patterns of Zip2 were found to be remarkably cell-type specific in pericentral hepatocytes, keratinocytes, and immature dendritic cells (33), but the loss of function of this gene also rendered mice more sensitive to zinc deficiency during pregnancy.

Here we examined the effects of a complete loss of function of the ZIP subfamily II genes in mice. Remarkably, although these genes are highly conserved and related to one another, the entire subfamily II is dispensable when dietary zinc is replete. Consistent with the conclusions from previous studies, the essential functions of these genes are apparently required only during periods of zinc deficiency, when they function in the accumulation/retention and distribution of dietary zinc. Compensatory functions among members of the Slc39a subfamily II are minimal, consistent with the concept that they evolved independent cell-specific functions in zinc homeostasis in mice.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animal care and use. Experiments with mice were performed in accordance with the guidelines from the National Institutes of Health for the care and use of animals and were approved by the Institutional Animal Care and Use Committee. Mouse diets were purchased from Dyets (Bethlehem, PA) and were identical except for zinc levels, which were as follows: zinc deficient: 1 ppm zinc; zinc adequate: 30 ppm zinc.

The effects of zinc deficiency during pregnancy on morphogenesis and growth of the embryo were determined as described in detail previously (5, 6, 9, 33). Female mice were mated (day 1 of pregnancy = vaginal plug) and provided free access to zinc-adequate feed and deionized distilled water until day 8 of pregnancy. Mice were then placed in pairs in cages with stainless steel false bottoms, and the diet was changed to the zinc-deficient feed. On day 14 of pregnancy, the embryos were collected and examined for gross morphological defects as described previously (5, 10) and presented in Fig. 2.


Figure 2
View larger version (50K):
[in this window]
[in a new window]

 
Fig. 2. Effects of dietary zinc deficiency during pregnancy on embryonic growth and morphogenesis in TKO and WT mice. Mice were fed a zinc-adequate (ZnA) or zinc-deficient (ZnD) diet beginning on day 8 of pregnancy, and the morphology of embryos was examined on day 14. A: embryos were divided into 3 groups based on morphology: normal, mildly affected, and severely affected. Embryos of normal size with well-formed forelimb digits and normal gross features were called Normal. Embryos that were smaller and had delayed formation of the forelimb digits but were otherwise apparently normal were called Mild; whereas those that were very small and had abnormal forelimbs and hindlimbs as well as craniofacial abnormalities were called Severe. B: an example of a normal normal ZnA TKO embryo and several severely affected ZnD TKO embryos.

 
The effect of zinc deficiency on the accumulation/retention of zinc was examined in weaned mice. Newly weaned mice (<5 days after weaning, 6 mice/group) were fed the zinc-adequate or the zinc-deficient diet for 1 wk. Food was withheld overnight, and mice were then given an oral gavage containing the stable isotope 67Zn (26, 30). The gavage solution was prepared as follows: zinc-deficient feed was dissolved in deionized water (1 g feed in 3 ml water), and the slurry was adjusted to 100 ppm of 67Zn. 67Zn (>94% enriched, 67zinc oxide) from Trace Sciences International (isotopetrace.com) was dissolved in 3 drops of concentrated HCl and then diluted to a final concentration of 5 mg/ml in distilled water. This stock solution was diluted 1:50 into the food slurry just before use. The pH of the gavage solution was neutral. Mice were given an oral gavage (100 µl food slurry containing 10 µg 67Zn), and tissues (liver, pancreas) were harvested at the indicated times after the gavage, rinsed in PBS, and prepared for elemental analysis as described below.

Zip1, Zip2, and Zip3 targeting vector construction. Bacterial artificial chromosomes that contain these mouse Zip genes from the 129/SvJ mouse strain were obtained from Incyte Genomics (incyte.com) and sequenced by Bruce Roe (University of Oklahoma).

The methods of construction and final structures of each targeting vector have been described in detail previously (5, 6, 33). Each targeting vector had the coding region of the EGFP cDNA from the vector pEGFPKT1loxneo introduced immediately downstream of the start codon. A loxP-flanked MC1-Neo cassette was immediately downstream of the EGFP cDNA, and the targeting vector was flanked by herpes simplex virus thymidine kinase and diphtheria toxin-negative selectable markers.

Targeted disruption of Zip genes in embryonic stem cells. Targeting vectors were linearized within the vector backbone and electroporated into RW4 embryonic stem (ES) cells. Colonies were selected with 300 µg/ml G418 (cellgro.com) and 2 µM gancyclovir (roche-applied-science.com). Homologous recombinants were screened for by Southern blot hybridization as described in detail previously for each knockout allele (5, 6, 33). Positive clones were subsequently screened with a Y-chromosome-specific probe derived from pY2 (28) and a Neo cDNA to detect the presence of a single-targeted MC1-Neo cassette.

Generation of Zip-knockout mice. Chimeric mice were generated by microinjection of ES cell clones into 3.5-day-old C57BL/6 blastocysts, followed by transfer to pseudopregnant CD-1 foster mothers. Resulting chimeric mice were crossed with C57BL/6 females (harlan.com). Germ line transmission was confirmed by PCR from tail DNA of agouti offspring.

The PCR screens for the targeted Zip alleles each utilized a set of three primers that directed amplification of the wild-type and the targeted alleles. The details of those primer sequences and where they anneal have been described previously (5, 6, 33). For the Zip1 targeted allele, the PCR product for the mutant allele was 433 bp and that for the wild-type allele was 328 bp. For the Zip2 targeted allele, the PCR product for the mutant allele was 319 bp and that for the wild-type allele was 403 bp. For the Zip3 targeted allele, the PCR product for the mutant allele was 326 bp and that for the wild-type allele was 461 bp.

Agouti offspring heterozygous for the knockout allele were crossed to generate homozygous knockout mice. To remove the loxP-flanked MC1-Neo cassette, knockout mice were mated with commercially available Cre-expressing transgenic mice [strain name: B6.FVB-TgN (EIIa-cre) C5379 Lmgd from JAX.org], which express Cre in all tissues. Zip-knockout mice that lacked the Neo cassette were crossed to generate homozygous knockout mice and wild-type mice.

Generation of Zip1, Zip2, Zip3 triple-knockout mice. Homozygous Zip1 and Zip3 mice were crossbred, and then offspring were backcrossed to generate homozygous double-knockout mice and wild-type mice as described previously (6). These double-knockout mice and wild-type mice were used to create working colonies. The double-knockout mice were then crossed with homozygous Zip2-knockout mice, yielding offspring heterozygous for each knockout allele. These mice were then crossed, and offspring homozygous for two of the knockout alleles and heterozygous for the third knockout allele were crossed. Offspring homozygous for all three knockout alleles were identified and crossed to create a working colony. Triple-knockout mice were compared with wild-type mice generated during creation of the double-knockout strain. All of the knockout lines and the wild-type line were therefore on a similar mixed genetic background.

RT-PCR amplification of Zip transcripts. Total RNA (5 µg) isolated from mouse liver with TRIzol according to the manufacturer's instructions (invitrogen.com) was reverse transcribed with Superscript III reverse transcriptase (RT) (invitrogen.com) and then amplified with Taq polymerase or LA-Taq polymerase (TAKARABio.com). Zip1 and Zip2 mRNAs were amplified for 30 cycles to yield 1,000-bp and 406-bp products, respectively, under reaction conditions described in detail previously (8). Zip3 mRNA was amplified with Zip3 sense (S) primer (5'-GTTCTTCTTCATGCTGCTGGGCTCCCTGCT-3') and Zip3 antisense (AS) primer (5'-GCACCAGGAACAGCACCTTCAGC-3') for 35 cycles to generate an 884-bp product. GAPDH was amplified with GAPDH (S) primer (5'-TCACGGCAAATTCAACGGCACAGTCAAGGC-3') and GAPDH (AS) primer (5'-CAGCACCAGTGGATGCAGGGATGATGTTCT-3'). Negative control reactions, in which the RT was omitted, were performed in parallel.

Membrane-bound alkaline phosphatase assay. The method of membrane preparation and the alkaline phosphatase assay were described in detail previously (35, 36). In brief, visceral yolk sacs and embryos (6 each) were collected on day 14 of pregnancy from wild-type and triple-knockout mice fed a zinc-adequate or zinc-deficient diet beginning on day 8. Samples were homogenized, and membranes were recovered from the postnuclear supernatant by centrifugation (100,000 g for 15 min at 4°C). The membrane pellet was suspended in buffer (10 mM Tris·HCl, pH 7.5, 0.5 mM MgCl2, and 0.1% Triton X-100) and frozen at –70°C until assayed. Membrane proteins (5 µg) were assayed for alkaline phosphatase activity with 2 mg/ml p-nitrophenyl phosphate in 1 M diethanolamine buffer, pH 9.8, containing 0.5 mM MgCl2. p-Nitrophenol release was measured by the absorbance at 405 nm. Antarctic phosphatase was used as a standard.

Western blot analysis. Membrane proteins from the visceral yolk sac, prepared for the alkaline phosphatase assay described above, were also examined by Western blotting. Membrane proteins (40 µg) were heated in 1x SDS-sample buffer at 37°C for 10 min, resolved on a 10% SDS-polyacrylamide gel, and transferred to polyvinylidene difluoride membranes. Membranes were blocked overnight and incubated with primary antibody as described previously (7, 19, 44). Immunoreactive bands were visualized with ECL Plus Western Blotting Detection System with Hyperfilm ECL (amershambiosciences.com). Anti-peptide antibodies against ZIP4 and ZIP1 have been generated and characterized as described previously (9, 19).

Trace metal determination. Elemental profiling via inductively coupled plasma mass spectrometry (ICP-MS) was performed for Na, Mg, P, K, Ca, Fe, Co, Cu, Zn, As, Se, and Mo as described in detail previously (33). In addition, the stable isotopes of zinc, 67Zn and 66Zn, were measured in each sample as indicated. The natural ratio of these zinc isotopes is 0.146. Mouse pancreata and livers (n = 4–6/group) were dried in a vacuum oven, digested in concentrated HNO3, and analyzed on an Elan DRCe ICP-MS (PerkinElmer). Methane was used as a collision cell gas to measure iron. Gallium and indium were used as internal standards. National Institute of Standards and Technology traceable single-element ICP standards (ultrasci.com) were used to make up the calibration standards.

Statistics. Experimental data were evaluated by Student's t-test. Data are presented as means ± SD. Differences were considered significant at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Creation of mice with no functional Slc39a subfamily II genes (Zip1, 2, and 3 triple-knockout mice). Zip1- and/or Zip3-knockout mice as well as Zip2-knockout mice were created as described previously (5, 6, 33). In each case, the targeting construct fused the initiator methionine codon with the open reading frame of the enhanced green fluorescent protein (EGFP) reporter.

Homozygous Zip1, Zip3 double-knockout mice were crossed with homozygous Zip2-knockout mice, and the offspring were genotyped and then backcrossed to ultimately yield homozygous triple-knockout mice. Wild-type mice, generated while creating Zip1, Zip3 double-knockout mice and Zip2-knockout mice, were crossed to yield a working colony. Successful creation of homozygous triple-knockout mice was verified by genotyping PCR, which showed amplification of only the knockout alleles in these mice (Fig. 1A) and by RT-PCR showing that these gene transcripts are absent in the adult liver of triple-knockout mice (Fig. 1B). These three Zip genes are expressed in a cell-specific pattern in the adult liver (6, 33).


Figure 1
View larger version (28K):
[in this window]
[in a new window]

 
Fig. 1. Confirmation of the genotype of triple-knockout mice with targeted deletions of the Zip1, Zip2, and Zip3 genes. A: PCR genotyping of wild-type (WT) and knockout alleles for Zip1, Zip2, and Zip3 genes in triple-knockout (TKO) mice. PCR reactions contained 3 primers each that directed the amplification of both WT and knockout alleles of these Zip genes as described in MATERIALS AND METHODS. Details of the targeting of each of these genes have been published previously (5, 6, 33). M, DNA ladder. B: RT-PCR detection of Zip1, Zip2, and Zip3 mRNAs in total liver RNA from WT and TKO mice. GAPDH served as an internal control for the RT-PCR. n.c., Samples in which the reverse transcriptase was omitted from the reaction.

 
Mice with no functional Zip1, 2, or 3 genes appeared normal when fed a zinc-adequate diet. There was no difference between wild-type and triple-knockout mice with regard to growth rate, pregnancy rate, litter size, or embryo growth and development (Fig. 2 and data not shown).

The triple-knockout mice showed no overt signs of zinc deficiency. On day 14 of pregnancy, the amount of membrane-bound alkaline phosphatase activity in the embryo (Fig. 3A), a zinc-dependent enzyme that is sensitive to zinc deficiency (36), and the abundance of ZIP4 protein in the visceral yolk sac (Fig. 3C), a sensitive indicator of zinc deficiency (7, 9, 44), were indistinguishable between the triple-knockout and wild-type mice.


Figure 3
View larger version (37K):
[in this window]
[in a new window]

 
Fig. 3. Effects of dietary zinc deficiency during pregnancy on embryonic membrane-bound alkaline phosphatase activity and ZIP4 protein abundance in TKO and WT mice. WT and TKO embryos (A) and their visceral yolk sacs (VYS; B) were collected (6/group) on day 14 of pregnancy from mice fed ZnA or ZnD diet beginning on day 8. Membranes were isolated from each tissue sample and assayed for alkaline phosphatase activity. Data are expressed as means ± SD from 6 determinations each. *Significant difference between ZnD TKO and WT (P < 0.001). C: Western blot detection of ZIP4 in membrane proteins from the day 14 VYS of WT and TKO embryos from samples used in A. Several ZIP4 peptides are detected, with a prominent band at ~37 kDa and another at ~75 kDa, as reported previously (44). ZIP1 was also detected by Western blotting of these same membrane preparations (middle), as described previously (44), and the proteins transferred to the membrane were detected by staining with Coomassie blue (bottom). NS, nonspecific bands. The minor band in the 5th lane (TKO ZnD) of the ZIP1 blot is an artifact that was not reproducible.

 
The initial accumulation/retention of exogenous zinc in the liver and pancreas was examined by giving mice an oral gavage containing the stable isotope 67Zn mixed into a slurry of zinc-deficient feed (100 ppm final Zn content). Liver and pancreas were harvested 30 min after the gavage, and the ratio of 67Zn to 66Zn was determined by ICP-MS (33). The natural ratio of these isotopes is 0.146. As shown in Fig. 4A, the initial rate of accumulation/retention of zinc was the same in triple-knockout and wild-type mice.


Figure 4
View larger version (13K):
[in this window]
[in a new window]

 
Fig. 4. Effects of dietary zinc status on the accumulation/retention of an oral gavage of 67Zn in the liver and pancreas of TKO and WT mice. Newly weaned WT and TKO mice were fed ZnA or ZnD diet for 7 days. Food was withheld overnight, and the next morning the mice (6/group) were given an oral gavage containing 67Zn mixed into a slurry of ZnD feed (10 µg zinc in 100 µl feed). This was considered a physiologically relevant dose of zinc. A: liver and pancreas were harvested 30 min after the gavage to detect the initial accumulation/retention of 67Zn in mice fed ZnA diet. B: liver and pancreas were harvested 3 h after the gavage to monitor the accumulation/retention of zinc in mice fed ZnD diet. Tissues were dehydrated, and multiple trace metals were measured by inductively coupled plasma mass spectrometry (ICP-MS). The ratio of the stable isotopes 67Zn to 66Zn in each sample was determined. The natural ratio of these isotopes of zinc is 0.146. Data are expressed as means ± SD from 6 determinations. *Significant difference between ZnD TKO and WT (liver, P = 0.014; pancreas, P = 0.029).

 
Effects of zinc deficiency during pregnancy on morphogenesis, membrane-bound alkaline phosphatase activity, and ZIP4 protein abundance in triple-knockout and wild-type mice. Our previous studies showed that the functions of ZIPs 1, 2, and 3 individually are not evident when dietary zinc is replete but become apparent when zinc is limiting. Therefore, we examined the effects of dietary zinc deficiency during pregnancy in triple-knockout and wild-type mice (Fig. 2A). Mice were fed a zinc-adequate or zinc-deficient diet beginning on day 8 of pregnancy, and embryos were examined on day 14 for morphological defects (Fig. 2B). Embryos in wild-type mice were relatively resistant to these conditions of zinc deficiency, and ~14% showed developmental defects when examined. These included growth retardation, abnormal limb development, and craniofacial abnormalities. Only a small percentage of wild-type embryos were severely affected (see Fig. 2 legend). In contrast, ~80% of the embryos in the triple-knockout mice were abnormal on day 14 and ~60% were severely affected (Fig. 2B).

Measurements of membrane-bound alkaline phosphatase activity in the embryo revealed that zinc deficiency caused a large reduction in the wild-type and triple-knockout embryos (Fig. 3A). However, triple-knockout embryos retained less than half the amount of enzyme activity (2.5 mU/µg membrane protein) relative to that in wild-type embryos (5.2 mU/µg membrane protein). The visceral yolk sac contains only low amounts of membrane-bound alkaline phosphatase activity that were not dramatically reduced by zinc deficiency (Fig. 3B). Together these results show that triple-knockout mice are very sensitive to dietary zinc deficiency during pregnancy.

Mouse ZIP4 plays a critical role in zinc homeostasis during development (10), and this protein is induced during periods of zinc deficiency in the visceral yolk sac. Western blot analysis of membranes from the visceral yolk sac demonstrated that ZIP4 is dramatically induced to the same extent during zinc deficiency in triple-knockout and wild-type mice (Fig. 3C). Thus this response to zinc deficiency is not impaired in the triple knockout, and ZIP4 cannot compensate for the loss of function of ZIPs 1, 2, and 3.

Triple-knockout mice show impaired accumulation/retention of oral 67Zn in liver and pancreas only when fed zinc-deficient diet. The above results suggest that triple-knockout mice may be impaired in the ability to accumulate zinc during periods of zinc deficiency. To test this possibility directly, weanling mice were fed a zinc-deficient diet for 7 days and then given an oral gavage (100 µl) containing 100 ppm of 67Zn mixed into a slurry of zinc-deficient feed. Liver and pancreas were harvested 3 h after the gavage, and the ratio of 67Zn to 66Zn was determined by ICP-MS (Fig. 4B). Wild-type mice accumulated/retained twice as much 67Zn in the liver and pancreas as triple-knockout mice within 3 h. By 6 h, the accumulation/retention of 67Zn in the liver and pancreas had increased in the triple-knockout mice but was highly variable between individuals (data not shown). These results are consistent with the concept that ZIP1, 2, and 3 function during periods of zinc deficiency to facilitate the accumulation/retention of zinc in the liver and pancreas.

Triple-knockout mice do not accumulate hepatic iron during zinc deficiency. Our previous study (33) demonstrated that Zip2-knockout mice fail to accumulate iron in the liver during periods of zinc deficiency. Whether ZIP1 and ZIP3 also play a role in iron metabolism in the liver is unknown. To explore this possibility, liver was collected from day 14 pregnant mice that had been fed the zinc-adequate or the zinc-deficient diet beginning on day 8 of pregnancy. Livers were dehydrated and subjected to elemental analysis by ICP-MS (Fig. 5). Iron content in the liver was indistinguishable in triple-knockout and wild-type mice fed the zinc-adequate diet, and during zinc deficiency iron content doubled in the liver of wild-type mice but remained unchanged in the triple-knockout mice (Fig. 5, A and C). These findings are similar to those reported in Zip2-knockout mice (33). Interestingly, zinc content in the liver was not clearly different between wild-type and triple-knockout mice, and the loss of zinc from the liver was not apparently exacerbated in the triple-knockout mice during zinc deficiency. However, it should be noted that only a small proportion (<20%) of total cellular zinc appears to be labile and a further loss of total zinc content leads to lethality.


Figure 5
View larger version (26K):
[in this window]
[in a new window]

 
Fig. 5. Accumulation of hepatic iron during zinc deficiency in WT but not in TKO mice. Pregnant WT and TKO mice were fed ZnD or ZnA diet beginning on day 8 of pregnancy, and the maternal liver was harvested on day 14. The liver (6/group) was dehydrated, and multiple trace metals were measured by ICP-MS. Data for iron (A and C) and zinc (B and D) are shown and are expressed as mean ± SD ratios to either selenium (A and B) or magnesium (C and D) from 6 determinations. No elements assayed in addition to zinc and iron showed reproducibly significant changes in these samples. *Significant difference between ZnD TKO and WT (Fe/Se, P < 0.001; Fe/Mg, P < 0.01).

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The evolution of two large gene families of zinc transporters in mammals is consistent with the complexity of essential metal homeostasis between different tissues and organs as well as within specific microenvironments both intra- and extracellular. There is a need to acquire the metal from varied diets, distribute the metal within the body, and accumulate, store, or eliminate the metal in a dynamic and often cell-specific manner. Mutations in many (7 of 10) of the ZnT gene family (Slc30a) of zinc transporters have been shown to cause overt phenotypes indicative of tissue-specific defects in zinc homeostasis in mice or humans (21, 22, 32). In contrast, to date only mutations in Zip4, among the nine Slc39a LIV-1 subfamily members, have been associated with zinc-deficient phenotypes in mice and humans (10, 43). The effects of mutations in other members of the LIV-1 family of zinc transporters in animals have not been reported, although many studies suggest that these genes play important roles in many fundamental cellular processes (38, 40).

The studies reported here focused on the effects of mutating three members of Slc39a subfamily II called Zip 1, 2, and 3. These genes have been well conserved during evolution. Mouse and human ZIP1 share 93% amino acid sequence identity (8). Structural (amino acid sequence) relatedness groups these three proteins into subfamily II (12). Remarkably, a complete loss of function of the entire subfamily II of genes in mice did not lead to overt signs of zinc deficiency based on several criteria. However, subfamily II genes were found to be important during periods of zinc deficiency in mice. The high degree of conservation of these genes suggests that their roles in protection against zinc deficiency are also important in humans, particularly during pregnancy.

Our previous studies (5, 6, 33) showed that knocking out the Zip1, Zip2, or Zip3 gene rendered mice more sensitive to the effects of zinc deficiency during pregnancy. Under the same experimental conditions used here, ~45% of the Zip1-knockout embryos and 36% of the Zip3-knockout embryos developed abnormally. In contrast, 91% of the embryos were abnormal in the double-knockout mice (Zip1 and Zip3) under these conditions. Zip1 and 3 genes appear to function in an additive manner in this model of zinc deficiency (6). Studies of Zip2-knockout mice under identical experimental conditions of zinc deficiency revealed that 57% of the Zip2-knockout embryos developed abnormally (33). This suggested that ZIP2 might have a more profound influence on zinc homeostasis than either ZIP1 or ZIP3 alone. Surprisingly, mice lacking all three of these Zip genes were not more sensitive to zinc deficiency than the Zip1, Zip3 double-knockout mice. Thus members of Slc39a subfamily II appear to have evolved unique noncompensatory functions during zinc deficiency. We previously reported (33) that ZIP2 plays a role in iron accumulation/retention in the liver during zinc deficiency; Zip2-knockout mice do not accumulate hepatic iron under these conditions. Whether ZIP1 and ZIP3 play roles in hepatic iron accumulation is unknown, but as shown here deletion of Zip1 and Zip3 did not modify this Zip2-knockout phenotype. These results are consistent with the concept that these three zinc transporters have evolved unique tissue- and cell-specific functions.

Results obtained from studying triple-knockout mice fed a zinc-adequate diet revealed that these genes are not essential for the rapid uptake and/or distribution of zinc in the body. In contrast, studies of these mice fed a zinc-deficient diet suggested a significant attenuation in the accumulation/retention of zinc in liver and pancreas. The amount of 67Zn accumulated in the pancreas and liver within 30 min in zinc-replete mice was twice that of the natural abundance of this isotope in these tissues. 67Zn represents 4.2% of the total natural Zn isotopes (64Zn > 66Zn = 68Zn >> 67Zn in relative abundance). In these zinc-replete mice an increase of 4.2% in total cellular zinc was detected within 30 min of the gavage. This is a reasonable approximation of a physiologically relevant amount. In the zinc-deficient mice, by 3 h after the gavage triple-knockout mice had accumulated only a small increase in total zinc in the liver (1.6% increase) and pancreas (1.1% increase), whereas the wild-type mice had accumulated 6.8% more zinc in the liver and 7.6% more zinc in the pancreas. Although these studies do not reveal the exact reason for these differences (uptake, distribution, retention) in zinc metabolism, they clearly reveal that these Zip genes play an important role(s) in zinc homeostasis during periods of zinc deficiency.

The physiological mechanisms of action of these, and most other, ZIPs remain to be determined. We hypothesize that on an organismal level, subfamily II members function in zinc homeostasis by controlling the distribution and/or retention of zinc in specific cells and organs. Zip1 and Zip3 are actively expressed in the lamina propria of the intestine and are thus unlikely to be important in the uptake of dietary zinc from the intestinal lumen (6). They may instead function in the distribution of zinc once it is acquired from the diet and transported through enterocytes. All three of these Zip genes are expressed in liver, surrounding the central vein in a remarkable gradient pattern. Zip2 is expressed at high levels exclusively in a single layer of pericentral hepatocytes (33). Zip1 and Zip3 are also expressed in these cells as well as in a gradient that diminishes away from the central vein in deeper layers of hepatocytes (5, 6). This pattern of expression suggests that these proteins function in the retention of zinc in the liver by preventing its escape into the central vein or that they function to collect zinc from the venous blood back into the liver. The cellular localization of these proteins in hepatocytes remains to be determined. These genetic studies indicate that these three zinc transporters are not essential for the rapid accumulation/retention of zinc in the liver when zinc is replete, that their functions are not interdependent, and that they function in the accumulation/retention of zinc in the liver (and pancreas) during periods of zinc deficiency. Zip2 appears to have a unique role in iron metabolism in the liver, although the mechanism is not understood (33).

Studies of ZIP1 and ZIP3 in transfected cells suggest that these proteins are recruited to the cell surface under zinc-deficient culture conditions (42), and in vivo studies of Zip1 expression and protein abundance do not suggest significant changes during zinc deficiency in the liver, intestine, and visceral yolk sac (Fig. 3C; Ref. 44), but studies of the cellular localization of these proteins in vivo have yielded conflicting results. ZIP1 can display different localization patterns in adherent vs. nonadherent cells, being vesicular in epithelial cell types and apical in K562 cells (31). Perhaps in vivo the localization of this protein reflects the microenvironment of each cell type. When zinc levels are low, these proteins may be moved to the cell surface. However, in the human prostate, which is very rich in zinc, ZIP1 plays a role in zinc uptake by normal cells, and diminished expression of this gene has been associated with prostate cancer (13). In contrast, overexpression of Zip1 inhibits growth of malignant PC-3 cells (14). There is little information on the role of zinc in the mouse prostate gland, but as yet we have seen no evidence for prostate or other tumors in the triple-knockout mouse colony. Whether these mice may be more prone to the induction of cancer remains to be examined. ZIP1 has also been reported to induce an osteogenic phenotype in transfected mesenchymal stem cells (37). We have noted no difference in the bone zinc content of triple-knockout vs. wild-type mice and no gross abnormalities in bone formation in the triple-knockout mice (J. Geiser and G. K. Andrews, unpublished observations).

ZIP3 has been proposed to play a major role in zinc uptake by mammary epithelial cells (23, 24) and even in the maintenance of viable mammary cells (24), but neonatal pups nursing from triple-knockout females showed no signs of zinc deficiency, unlike the lethal milk mutant phenotypes (34) or the phenotypes noted during dietary zinc deficiency while nursing. Perhaps ZIP3 functions transiently during lactation but its absence and the absence of the all subfamily II members does not lead to obvious phenotypic abnormalities in mice when zinc replete. ZIP3 does not appear to play a pivotal physiological role in the survival of functional secretory mammary epithelial cells in mice.

The functions of ZIP2 are clearly unique from those of ZIP1 and ZIP3, as is its pattern of expression. ZIP2 influences calcium and iron metabolism in zinc-deficient embryos and liver, respectively (33). ZIP14 (39) was recently reported to mediate transport of non-transferrin-bound iron into hepatocytes (29), although this finding has recently been challenged (15). Our studies reveal that ZIP2 plays a unique role in iron accumulation in the liver. Whether ZIP2 can transport iron is under investigation.

Perspectives and Significance

The molecular mechanisms regulating zinc homeostasis in mammals are important to understand because zinc deficiency is a worldwide problem that affects hundreds of thousands of children in particular. A deficiency of zinc causes a multitude of negative physiological effects during periods of rapid growth and differentiation. It is thought that the 14 members of the Slc39a family are critical for the uptake of zinc into cells, but the physiological functions of most remain obscure. Here we report studies of three highly conserved members (ZIPs 1 to 3) that compose subfamily II. These studies show that this family of genes have evolved to function during periods of dietary zinc deficiency but are dispensable when dietary zinc is replete. They play important, noncompensatory roles consistent with their tissue-specific patterns of expression. Although much remains to be learned about the structure, function, and regulation of the mammalian ZIP proteins, our studies show that mutations in these Zip genes can modify sensitivity to the stress of dietary zinc deficiency and could therefore be important in human health.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This study was funded, in part, by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-059369 to G. K. Andrews. T. Kambe was supported, in part, by a fellowship from the Kanae Foundation for the Promotion of Medical Science.


    ACKNOWLEDGMENTS
 
We thank Drs. Mario Capecchi and Richard Palmiter for gene targeting vectors and members of the Transgenic and Gene-Targeting Facility at the University of Kansas Medical Center for generating chimeric mice. We also wish to thank Dr. Bruce Roe at the University of Oklahoma for bacterial artificial chromosome sequencing.

Present address of T. Kambe: Div. of Integrated Life Science, Graduate School of Biostudies, Kyoto University, Kyoto 606-8502, Japan (e-mail: kambe1{at}kais.kyoto-u.ac.jp).


    FOOTNOTES
 

Address for reprint requests and other correspondence: G. K. Andrews, Dept. of Biochemistry and Molecular Biology, Mail Stop 3030, Univ. of Kansas Medical Center, 39th and Rainbow Blvd., Kansas City, KS 66160-7421 (e-mail: gandrews{at}kumc.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

* T. Kambe and J. Geiser contributed equally to this work. Back


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Andrews GK, Wang H, Dey SK, Palmiter RD. Mouse zinc transporter 1 gene provides an essential function during early embryonic development. Genesis 40: 74–81, 2004.[CrossRef][Web of Science][Medline]
  2. Chowanadisai W, Lonnerdal B, Kelleher SL. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 281: 39699–39707, 2006.[Abstract/Free Full Text]
  3. Cole TB, Robbins CA, Wenzel HJ, Schwartzkroin PA, Palmiter RD. Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 39: 153–169, 2000.[CrossRef][Web of Science][Medline]
  4. Cousins RJ, Liuzzi JP, Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem 281: 24085–24089, 2006.[Free Full Text]
  5. Dufner-Beattie J, Huang ZL, Geiser J, Xu W, Andrews GK. Generation and characterization of mice lacking the zinc uptake transporter ZIP3. Mol Cell Biol 25: 5607–5615, 2005.[Abstract/Free Full Text]
  6. Dufner-Beattie J, Huang ZL, Geiser J, Xu W, Andrews GK. Mouse ZIP1 and ZIP3 genes together are essential for adaptation to dietary zinc deficiency during pregnancy. Genesis 44: 239–251, 2006.[CrossRef][Web of Science][Medline]
  7. Dufner-Beattie J, Kuo YM, Gitschier J, Andrews GK. The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc-regulation of the zinc transporters ZIP4 and ZIP5. J Biol Chem 279: 49082–49090, 2004.[Abstract/Free Full Text]
  8. Dufner-Beattie J, Langmade SJ, Wang F, Eide D, Andrews GK. Structure, function, and regulation of a subfamily of mouse zinc transporter genes. J Biol Chem 278: 50142–50150, 2003.[Abstract/Free Full Text]
  9. Dufner-Beattie J, Wang F, Kuo YM, Gitschier J, Eide D, Andrews GK. The acrodermatitis enteropathica gene ZIP4 encodes a tissue-specific, zinc-regulated zinc transporter in mice. J Biol Chem 278: 33474–33481, 2003.[Abstract/Free Full Text]
  10. Dufner-Beattie J, Weaver BP, Geiser J, Bilgen M, Larson M, Xu W, Andrews GK. The mouse acrodermatitis gene Slc39a4 (ZIP4) is essential for development and heterozygosity causes hypersensitivity to zinc deficiency. Hum Mol Genet 16: 1391–1399, 2007.[Abstract/Free Full Text]
  11. Eide DJ. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763: 711–722, 2006.[Medline]
  12. Eng BH, Guerinot ML, Eide D, Saier MH Jr. Sequence analyses and phylogenetic characterization of the ZIP family of metal ion transport proteins. J Membr Biol 166: 1–7, 1998.[CrossRef][Web of Science][Medline]
  13. Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 4: 32–45, 2005.[CrossRef][Medline]
  14. Franklin RB, Ma J, Zou J, Guan Z, Kukoyi BI, Feng P, Costello LC. Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. J Inorg Biochem 96: 435–442, 2003.[CrossRef][Web of Science][Medline]
  15. Girijashanker K, He L, Soleimani M, Reed JM, Liu Z, Wang B, Li H, Dalton TP, Nebert DW. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol (February 12, 2008). doi: 10.1124/mol.107.043588.[Abstract/Free Full Text]
  16. Guerinot ML. The ZIP family of metal transporters. Biochim Biophys Acta 1465: 190–198, 2000.[Medline]
  17. Huang L, Yu YY, Kirschke CP, Gertz ER, Lloyd KK. Znt7 (Slc30a7)-deficient mice display reduced body zinc status and body fat accumulation. J Biol Chem 282: 37053–37063, 2007.[Abstract/Free Full Text]
  18. Huang LP, Gitschier J. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nat Genet 17: 292–297, 1997.[CrossRef][Web of Science][Medline]
  19. Huang ZL, Dufner-Beattie J, Andrews GK. Expression and regulation of SLC39A family zinc transporters in the developing mouse intestine. Dev Biol 295: 571–579, 2006.[CrossRef][Web of Science][Medline]
  20. Inoue K, Matsuda K, Itoh M, Kawaguchi H, Tomoike H, Aoyagi T, Nagai R, Hori M, Nakamura Y, Tanaka T. Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5. Hum Mol Genet 11: 1775–1784, 2002.[Abstract/Free Full Text]
  21. Kambe T, Weaver BP, Andrews GK. The genetics of essential metal homeostasis during development. Genesis. In press.
  22. Kambe T, Yamaguchi-Iwai Y, Sasaki R, Nagao M. Overview of mammalian zinc transporters. Cell Mol Life Sci 61: 49–68, 2004.[CrossRef][Web of Science][Medline]
  23. Kelleher SL, Lonnerdal B. Zn transporter levels and localization change throughout lactation in rat mammary gland and are regulated by Zn in mammary cells. J Nutr 133: 3378–3385, 2003.[Abstract/Free Full Text]
  24. Kelleher SL, Lonnerdal B. Zip3 plays a major role in zinc uptake into mammary epithelial cells and is regulated by prolactin. Am J Physiol Cell Physiol 288: C1042–C1047, 2005.[Abstract/Free Full Text]
  25. Kirschke CP, Huang LP. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem 278: 4096–4102, 2003.[Abstract/Free Full Text]
  26. Krebs NF, Miller LV, Naake VL, Lei S, Westcott JE, Fennessey PV, Hambidge KM. The use of stable isotope techniques to assess zinc metabolism. J Nutr Biochem 6: 292–301, 1995.[CrossRef][Web of Science]
  27. Kury S, Dreno B, Bezieau S, Giraudet S, Kharfi M, Kamoun R, Moisan JP. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 31: 239–240, 2002.[CrossRef][Web of Science][Medline]
  28. Lamar EE, Palmer E. Y-encoded, species-specific DNA in mice: evidence that the Y chromosome exists in two polymorphic forms in inbred strains. Cell 37: 171–177, 1984.[CrossRef][Web of Science][Medline]
  29. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci USA 103: 13612–13617, 2006.[Abstract/Free Full Text]
  30. Miller LV, Krebs NF, Hambidge KM. Human zinc metabolism: advances in the modeling of stable isotope data. Adv Exp Med Biol 445: 253–269, 1998.[Web of Science][Medline]
  31. Milon B, Dhermy D, Pountney D, Bourgeois M, Beaumont C. Differential subcellular localization of hZip1 in adherent and non-adherent cells. FEBS Lett 507: 241–246, 2001.[CrossRef][Web of Science][Medline]
  32. Palmiter RD, Huang L. Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflügers Arch 447: 744–751, 2004.[CrossRef][Web of Science][Medline]
  33. Peters JL, Dufner-Beattie J, Xu W, Geiser J, Lahner B, Salt DE, Andrews GK. Targeting of the mouse Slc39a2 (Zip2) gene reveals highly cell-specific patterns of expression, and unique functions in zinc, iron, and calcium homeostasis. Genesis 45: 339–352, 2007.[CrossRef][Web of Science][Medline]
  34. Piletz JE, Lonnerdal B, Hurley LS, Berry W, Ganschow RE, Herschman HR. Zinc and copper in milk and tissues of nursing lethal milk mutant mice. J Nutr 117: 83–90, 1987.[Abstract/Free Full Text]
  35. Suzuki T, Ishihara K, Migaki H, Ishihara K, Nagao M, Yamaguchi-Iwai Y, Kambe T. Two different zinc transport complexes of cation diffusion facilitator proteins localized in the secretory pathway operate to activate alkaline phosphatases in vertebrate cells. J Biol Chem 280: 30956–30962, 2005.[Abstract/Free Full Text]
  36. Suzuki T, Ishihara K, Migaki H, Matsuura W, Kohda A, Okumura K, Nagao M, Yamaguchi-Iwai Y, Kambe T. Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane. J Biol Chem 280: 637–643, 2005.[Abstract/Free Full Text]
  37. Tang Z, Sahu SN, Khadeer MA, Bai G, Franklin RB, Gupta A. Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. Bone 38: 181–198, 2006.[Medline]
  38. Taylor KM, Hiscox S, Nicholson RI. Zinc transporter LIV-1: a link between cellular development and cancer progression. Trends Endocrinol Metab 15: 461–463, 2004.[CrossRef][Web of Science][Medline]
  39. Taylor KM, Morgan HE, Johnson A, Nicholson RI. Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett 579: 427–432, 2005.[CrossRef][Web of Science][Medline]
  40. Taylor KM, Morgan HE, Smart K, Zahari NM, Pumford S, Ellis IO, Robertson JF, Nicholson RI. The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol Med 13: 396–406, 2007.[Web of Science][Medline]
  41. Taylor KM, Nicholson RI. The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim Biophys Acta 1611: 16–30, 2003.[Medline]
  42. Wang F, Dufner-Beattie J, Kim BE, Petris MJ, Andrews G, Eide DJ. Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters. J Biol Chem 279: 24631–24639, 2004.[Abstract/Free Full Text]
  43. Wang K, Zhou B, Kuo YM, Zemansky J, Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 71: 66–73, 2002.[CrossRef][Web of Science][Medline]
  44. Weaver BP, Dufner-Beattie J, Kambe T, Andrews GK. Novel zinc-responsive post-transcriptional mechanisms reciprocally regulate expression of the mouse Slc39a4 and Slc39a5 zinc transporters (Zip4 and Zip5). Biol Chem 388: 1301–1312, 2007.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. L. Kelleher, V. Lopez, B. Lonnerdal, J. Dufner-Beattie, and G. K. Andrews
Zip3 (Slc39a3) functions in zinc reuptake from the alveolar lumen in lactating mammary gland
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R194 - R201.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Kambe and G. K. Andrews
Novel Proteolytic Processing of the Ectodomain of the Zinc Transporter ZIP4 (SLC39A4) during Zinc Deficiency Is Inhibited by Acrodermatitis Enteropathica Mutations
Mol. Cell. Biol., January 1, 2009; 29(1): 129 - 139.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/R1474    most recent
00130.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kambe, T.
Right arrow Articles by Andrews, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kambe, T.
Right arrow Articles by Andrews, G. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.